Clinical trial Recruiting at 1 site Interventional Ages 12 Months to 18

Effect of heated foods on remission in children with Eosinophilic Esophagitis

Official title: Pediatric Eosinophilic Esophagitis (pedEoE): Effect of Allergen Heat Denaturation on EoE Remission: a Pilot Trial

Run by Universitaire Ziekenhuizen KU Leuven · NCT06381219 · Data updated 2026-11-12

This study is testing if giving heated versions of hen's egg and cow's milk can help children with Eosinophilic Esophagitis stay in remission and possibly build tolerance to these foods.

More Eosinophilic Esophagitis trials

Quick facts

Study typeInterventional
Ages12 Months to 18 Years
SexAll
Enrollment36 (estimated)
SponsorUniversitaire Ziekenhuizen KU Leuven
Academic / other
Locations1 site (Leuven, Vlaams-Brabant)
StatusRecruiting
StartedDecember 19, 2023
Main results expectedDecember 31, 2027
Study endsDecember 31, 2028
Registry record updatedMay 5, 2026
Trial IDNCT06381219 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children aged 12 months and older with a diagnosis of EoE induced by cow's milk or hen's egg who are currently in remission.

Probably not a fit

Patients who are younger than 12 months or have active EoE will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot trial investigates whether introducing heated food products, specifically hen's egg and cow's milk, can help maintain remission in children with Eosinophilic Esophagitis (EoE). The study involves a controlled food challenge where children will consume heated versions of these allergens, followed by gradual reintroduction of less heated forms. Participants will undergo regular gastroscopies to assess eosinophil levels in biopsies, which will indicate remission status. The goal is to determine if this approach can lead to tolerance induction in affected children.

Why it matters

Potential benefit: If successful, this study could provide a new dietary management strategy for children with EoE, potentially improving their quality of life.

How similar studies have gone: While this approach is novel, similar studies exploring dietary interventions in EoE have shown promise, suggesting potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

All children (aged 12 months and older) presenting (since 1-1-2014: moment of diagnostic guideline standardization for pedEoE) with diagnosed pedEoE at UZ Leuven eliminating either hen's egg or cow's milk or both and in complete remission after their latest biopsy (no longer than 12 months earlier, but preferentially as short as possible after their latest biopsy) are eligible for the study. If the last biopsy has been performed more than 12 months earlier, a new gastro-duodenoscopy will be performed to verify remission and rule out e.g. active gastritis. If they are on PPI and/or local budesonide treatment, this should be stable for at least 3 months and will remain untouched during the entire study. We will include 18 pedEoE subjects suffering from cow's milk induced EoE and 18 suffering from hen's egg induced EoE.

Exclusion Criteria:

* Children younger than 12 months
* Children with active pedEoE
* Children who refuse to adhere to the protocol
* Children with associated IgE mediated hen's egg and/or cow's milk allergy with specific IgE antibody titers that predict active (baked egg and/or baked milk) food allergy with cut-off titers as used at the consultation of allergy (KLL). Those children will become eligible however if their titers decrease while the study is still open.

Where it's running

  • UZ Leuven Gasthuisberg
    Leuven, Vlaams-Brabant, Belgium
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.